+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microbiology Culture, Immunoassay, PCR, NGS), By Pathogen, By End User, By Region, And Segment Forecasts, 2022 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 5702233
Description Jump to:
The global antimicrobial resistance diagnostics market size is expected to reach USD 6.7 billion by 2030. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increased risk of developing drug-resistant bacterial infections, especially in healthcare facilities, and increasing government & non-government bodies’ efforts to combat the threat of AMR are the major factor contributing to market growth. In addition, various strategic initiatives undertaken by leading market players to manage antimicrobial resistance are also contributing to market expansion. For instance, in March 2021, bioMerieux and GIZ collaborated to support the Nigerian center for disease control to strengthen the fight against AMR.

The rising adoption of rapid testing and PoC tests for drug-resistant bacterial infections is anticipated to augment the market over the projected period. Moreover, leading market players such as Danaher, Abbott, and others have a robust product portfolio of rapid diagnostic tests for antimicrobial-resistant infections. Furthermore, the increasing involvement of non-government bodies such as AMR Industry Alliance is assisting regulatory bodies to make strategies to boost the development of diagnostic solutions to manage antimicrobial resistance.

Increasing funding for the development of novel and automated test solutions for the diagnosis of antimicrobial-resistant infections is anticipated to boost market growth over the forecast period. For instance, in May 2022, the European Investment Bank funded more than USD 24 million to POCARED Diagnostics for the R&D of fully automated testing of microbial diseases. POCARED Diagnostics is involved in the development of novel microbiology tests that can provide results within hours.

Antimicrobial resistance is expected to rise in the coming years. Hence, demand for accurate & fast testing options is expected to increase for the effective management and progression monitoring of antimicrobial resistance. According to the CDC, the annual direct healthcare expenditure of antimicrobial resistance is around USD 20 billion in the U.S. High cost of disease management is driving the demand for rapid tests for the diagnosis of infections at an early stage.

Key market players are continuously involved in the development of novel tests to strengthen their market position. Moreover, other strategies such as acquisitions, partnerships, and collaborations are also adopted by leading players to expand their product portfolio in different parts of the globe. For instance, in August 2022, Accelerate Diagnostics and BD announced a collaboration to combat the threat of antimicrobial resistance. As per the deal, BD will provide Accelerate Diagnostics rapid diagnostic solutions for antibiotics-associated resistance to its vast customers.

Antimicrobial Resistance Diagnostics Market Report Highlights

  • PCR held the largest share of the technology segment in 2021 owing to the high penetration and technological advancements
  • Based on pathogen segment, the Methicillin resistant staphylococcus aureus accounted for the largest share in 2021 due to the high incidence rate of MRSA infections and the surge in product launches
  • In end-user, the hospital segment was the highest revenue contributor in 2021 because of higher patient admissions and high incidence of bacterial infections
  • In Asia Pacific, the market is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Antimicrobial Resistance Diagnostics Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increase in risk of developing drug - resistant bacterial infections
3.2.1.2 Introduction of novel technologies to diagnose AMR infections
3.2.1.3 Favorable government initiatives
3.2.2 Market restraint analysis
3.2.2.1 Presence of stringent rules and regulations pertaining to diagnostics
3.3 Penetration & Growth Prospect Mapping
3.4 Antimicrobial Resistance Diagnostics: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Technology, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Technology Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Antimicrobial Resistance Diagnostics Market, by Technology, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Microbiology Culture
4.5.1.1 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2 Immunoassay
4.5.2.1 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3 PCR
4.5.3.1 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.4 NGS
4.5.4.1 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.5 Mass Spectrometry
4.5.5.1 Mass Spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.6 Rapid & Point of Care
4.5.6.1 Rapid & Point of Care market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.7 Others
4.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Pathogen 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Pathogen Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Antimicrobial Resistance Diagnostics Market, by Pathogen, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Drug Resistant Streptococcus Pneumoniae (DRSP)
5.5.1.1 Drug resistant streptococcus pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2 Drug Resistant Campylobacter (DRC)
5.5.2.1 Drug resistant campylobacter (DRC) market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3 Clostridium Difficile (CD)
5.5.3.1 Clostridium difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4 Methicillin Resistant Staphylococcus Aureus (MRSA)
5.5.4.1 Methicillin resistant staphylococcus aureus (MRSA) market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.5 Drug Resistant Neisseria Gonorrhoeae (DRNG)
5.5.5.1 Drug resistant neisseria gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.6 Drug Resistant Salmonella (DRNTS)
5.5.6.1 Drug resistant salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.7 Others
5.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 Antimicrobial Resistance Diagnostics Market Segment Analysis, By End User, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 End User Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Antimicrobial Resistance Diagnostics Market, by End User, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Hospitals
6.5.1.1 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2 Diagnostic Laboratories
6.5.2.1 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3 Pharmaceutical & Biotechnology Companies
6.5.3.1 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4 Others
6.5.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 SWOT Analysis
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East and Africa
7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
7.6.1 North America
7.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.6.1.2 U.S.
7.6.1.2.1 U.S. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.1.3 Canada
7.6.1.3.1 Canada antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2 Europe
7.6.2.1 Europe antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2.2 U.K.
7.6.2.2.1 U.K. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2.3 Germany
7.6.2.3.1 Germany antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2.4 Spain
7.6.2.4.1 Spain antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2.5 France
7.6.2.5.1 France antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2.6 Italy
7.6.2.6.1 Italy antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3 Asia Pacific
7.6.3.1 Asia Pacific antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3.2 Japan
7.6.3.2.1 Japan antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3.3 China
7.6.3.3.1 China antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3.4 India
7.6.3.4.1 India antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3.5 South Korea
7.6.3.5.1 South Korea antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3.6 Australia
7.6.3.6.1 Australia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4 Latin America
7.6.4.1 Latin America antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4.2 Brazil
7.6.4.2.1 Brazil antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4.3 Mexico
7.6.4.3.1 Mexico antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4.4 Argentina
7.6.4.4.1 Argentina antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5 MEA
7.6.5.1 MEA antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5.2 South Africa
7.6.5.2.1 South Africa antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5.3 Saudi Arabia
7.6.5.3.1 Saudi Arabia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5.4 UAE
7.6.5.4.1 UAE antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Antimicrobial Resistance Diagnostics Market - Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Ansoff matrix
8.1.2 Heat map analysis
8.1.3 Major Deals and Strategic Alliances Analysis
8.1.3.1 Joint Ventures
8.1.3.2 Licensing Agreements
8.1.3.3 Product Launches
8.1.3.4 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.4.1.1 Market Differentiators
8.5 Private Companies
8.5.1 List of key emerging companies
8.6 Company Profiles
8.6.1 bioMerieux
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic initiatives
8.6.2 F. Hoffmann - La Roche Ltd
8.6.2.1 Company overview
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic initiatives
8.6.3 Abbott
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic initiatives
8.6.4 BD
8.6.4.1 Company overview
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic initiatives
8.6.5 Danaher
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic initiatives
8.6.6 Accelerate Diagnostics, Inc.
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic initiatives
8.6.7 Molsid
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 Vela Diagnostics
8.6.8.1 Company overview
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 Visby Medical, Inc.
8.6.9.1 Company overview
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.9.4 Strategic initiatives
8.6.10 Hologic, Inc.
8.6.10.1 Company overview
8.6.10.2 Financial performance
8.6.10.3 Product benchmarking
8.6.10.4 Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Leading market players anticipated to witness highest growth
Table 4 Global Antimicrobial Resistance Diagnostics Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 6 Global Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
Table 7 Global Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 8 North America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 10 North America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 11 North America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 12 U.S. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 13 U.S. Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
Table 14 U.S. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 15 Canada Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 16 Canada Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
Table 17 Canada Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 18 Europe Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 20 Europe Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 21 Europe Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 22 Germany Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 23 Germany Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
Table 24 Germany Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 25 France Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 26 France Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 27 France Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 28 U.K. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 29 U.K. Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 30 U.K. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 31 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 32 Spain Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
Table 33 Spain Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 34 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 35 Italy Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
Table 36 Italy Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 37 Italy Antimicrobial Resistance Diagnostics Market, By Application, 2018 - 2030 (USD Million)
Table 38 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 42 Japan Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 43 Japan Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 44 Japan Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 45 China Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 46 China Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 47 China Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 48 India Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 49 India Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 50 India Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 51 Australia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 52 Australia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 53 Australia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 54 South Korea Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 55 South Korea Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 56 South Korea Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 57 Latin America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 58 Latin America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 59 Latin America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 60 Latin America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 61 Brazil Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 62 Brazil Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 63 Brazil Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 64 Mexico Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 65 Mexico Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 66 Mexico Antimicrobial Resistance Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
Table 67 Argentina Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 68 Argentina Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 69 Argentina Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 70 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 71 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 72 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 73 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)
Table 74 South Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 75 South Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 76 South Africa Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
Table 80 UAE Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 81 UAE Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
Table 82 UAE Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Antimicrobial resistance diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2020)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Antimicrobial resistance diagnostics market: technology movement analysis
Fig. 17 Antimicrobial resistance diagnostics market: technology segment dashboard
Fig. 18 Antimicrobial resistance diagnostics market technology outlook: Key takeaways
Fig. 19 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Rapid & point of care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Antimicrobial resistance diagnostics market: pathogen analysis
Fig. 27 Antimicrobial resistance diagnostics market: pathogen segment dashboard
Fig. 28 Antimicrobial resistance diagnostics market pathogen outlook: Key takeaways
Fig. 29 Drug Resistant Streptococcus Pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Drug Resistant Campylobacter (DRC)market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Clostridium Difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Methicillin Resistant Staphylococcus Aureus (MRSA)market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Drug Resistant Neisseria Gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Drug Resistant Salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Antimicrobial resistance diagnostics market: end user movement analysis
Fig. 37 Antimicrobial resistance diagnostics market: end user segment dashboard
Fig. 38 Antimicrobial resistance diagnostics market, end user outlook: Key takeaways
Fig. 39 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Regional outlook estimates and forecasts, 2021 & 2030
Fig. 44 Regional market dashboard
Fig. 45 Regional market place: Key takeaways
Fig. 46 North America, SWOT
Fig. 47 Europe, SWOT
Fig. 48 Asia Pacific, SWOT
Fig. 49 Latin America, SWOT
Fig. 50 Middle East and Africa, SWOT
Fig. 51 North America
Fig. 52 North America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 53 U.S.
Fig. 54 U.S. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 55 Canada
Fig. 56 Canada antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 57 Europe
Fig. 58 Europe antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 59 U.K.
Fig. 60 U.K. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 61 Germany
Fig. 62 Germany antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 63 Spain
Fig. 64 Spain antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 65 France
Fig. 66 France antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 67 Italy
Fig. 68 Italy antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific
Fig. 70 Asia Pacific antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 71 Japan
Fig. 72 Japan antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 73 China
Fig. 74 China antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 75 India
Fig. 76 India antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 77 South Korea
Fig. 78 South Korea antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 79 Australia
Fig. 80 Australia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 81 Latin America
Fig. 82 Latin America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 83 Brazil
Fig. 84 Brazil antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 85 Mexico
Fig. 86 Mexico antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 87 Argentina
Fig. 88 Argentina antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 89 Middle East and Africa
Fig. 90 MEA antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 91 South Africa
Fig. 92 South Africa antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 93 Saudi Arabia
Fig. 94 Saudi Arabia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 95 UAE
Fig. 96 UAE antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
Fig. 97 Ansoff Matrix
Fig. 98 Heat map analysis
Fig. 99 Market differentiators

Companies Mentioned

  • Biomerieux
  • F. Hoffmann - La Roche Ltd
  • Abbott
  • Bd
  • Danaher
  • Accelerate Diagnostics, Inc.
  • Molsid
  • Vela Diagnostics
  • Visby Medical, Inc.
  • Hologic, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedNovember 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 4.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.7 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Antimicrobial Resistance Surveillance Market by Component (Diagnostic Kits, Diagnostic Systems, Services), End-User (Hospitals, Research & Academic Institutes) - Forecast 2024-2030 - Product Image

Global Antimicrobial Resistance Surveillance Market by Component (Diagnostic Kits, Diagnostic Systems, Services), End-User (Hospitals, Research & Academic Institutes) - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) - Global Forecast to 2028 - Product Image

Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) - Global Forecast to 2028

  • Report
  • 200 Pages
  • Global
From
Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027 - Product Image

Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027

  • Report
  • 373 Pages
  • Global
From
Antimicrobial Resistance Market By Drug Class, By Pathogen, By Indication, By Mechanism of Action: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Antimicrobial Resistance Market By Drug Class, By Pathogen, By Indication, By Mechanism of Action: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 389 Pages
  • Global
From
Antimicrobial Resistance (AMR) - Pipeline Insight, 2024 - Product Image

Antimicrobial Resistance (AMR) - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.